Executive Director of Imperial College Innovations Ltd
Andrew Tingey is an Executive Director of Imperial College Innovations Ltd, the company that transacts commercial intellectual property deals for Imperial College London. Andrew is also Director of the Commercialisation Office, which is Imperial’s centre for IP policy, post-signature IP deal management and start-up creation. Before moving to the College, Andrew was a Director of Imperial Innovations Ltd. and led the team that sourced, developed and licensed new technologies in the healthcare sector from Imperial College London before technology transfer operations were transferred back “in-house” to Imperial College.
Previously, Andrew was Director of Licensing at Royal DSM NV, where he led the DSM corporate licensing team based near Maastricht, the Netherlands. Andrew had formerly held successive positions as group portfolio licensing manager at Fusion IP plc and senior managerial and R&D roles at Reading Scientific Services Ltd, an independent scientific analysis, consultancy, product development and training company.
Andrew has held Certified Licensing Professional accreditation since 2012 and also holds a PhD in biochemistry from the University of Leicester, a BSc in biochemistry from the University of York and an MBA from The Open University Business School in the United Kingdom.